If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0675    -0.005 (-6.90%)
Bid:
0.065
Ask:
0.07
Spread: 0.005 (7.692%)
Market Cap: £3.86m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Option Purchase and Exercise

13 Mar 2017 10:30

RNS Number : 2649Z
Empyrean Energy PLC
13 March 2017
 

This announcement contains inside information

 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

13 March 2017

Empyrean Energy PLC ('Empyrean' or 'the Company')

 

Option Purchase and Exercise

 

Empyrean confirms that it was notified that on 10 March 2017 that Apnea Holdings Pty Ltd ("Apnea"), a company which is wholly-owned by Tom Kelly, CEO of Empyrean, on that date purchased options (the "Options") in respect of 63,000,000 ordinary shares of 0.2p each in in the Company ("Ordinary Shares") from a third party not connected with the Company (the "Seller"). The terms of the Options are set out below and the total consideration payable by Apnea in respect of the purchase of the Options was AU$275,000 (equivalent to approximately £171,000).

 

Number of Options

Exercise Price

Expiry Date

18,000,000

0.2 pence

19 July 2017

15,000,000

2.1 pence

19 July 2017

15,000,000

4.1 pence

25 March 2018

15,000,000

2.1 pence

26 July 2019

 

Further to the announcement on 15 December 2016, the first tranche of Options detailed above reflects the agreement reached between the Company and the Seller that, if this tranche of Options were to be exercised prior to shareholder approval being granted for the necessary capitalisation from reserves to allow the exercise price to be amended to 0.1p, then this tranche of Options would have an exercise price of 0.2p and convert into a greater number of 18,000,000 Ordinary Shares.

 

Empyrean also announces that, on 10 March 2017, it received notice from Apnea that it intended to exercise its option in relation to 18,000,000 Ordinary Shares at an exercise price of 0.2 pence each. Accordingly, the Company has issued and allotted 18,000,000 Ordinary Shares (the "New Ordinary Shares"). Application will be made for the New Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on 17 March 2017. These New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following this exercise, Tom Kelly has a beneficial interest in 38,881,563 Ordinary Shares, representing 16.21% per cent. of the enlarged issued share capital of the Company.

 

Following the transaction, Empyrean's total issued share capital will comprise 239,833,853 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

**ENDS**

 

Empyrean Energy plc

Tom Kelly

Tel: +61 8 9481 0389

Cenkos Securities plc

Neil McDonald

Tel: +44 (0) 131 220 9771

Beth McKiernan

Tel: +44 (0) 131 220 9778

Nick Tulloch

Tel: +44 (0) 131 220 9772

St Brides Partners Ltd

Elisabeth Cowell

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

Tel: +44 (0) 20 7236 1177

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tom Kelly

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer of the Company

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Empyrean Energy plc

b)

LEI

-

4.

Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Options over ordinary shares of 0.2p each ("Ordinary Shares")

Identification code

GB00B09G2351

b)

Nature of the Transaction

Purchase of options in respect of 63,000,000 Ordinary Shares and subsequent exercise of options in respect of 18,000,000 Ordinary Shares at 0.2p per Ordinary Share.

c)

Price(s) and volume(s)

Price

Volume

AU$275,000 (aggregate) (equivalent to approximately £171,000)

Options in respect of 63,000,000 Ordinary Shares with an exercise price of 0.2p to 4.1p per Ordinary Share

 Price

Volume

0.2p

18,000,000

d)

Aggregated information

Aggregated volume Price

N/A (Single transaction)

e)

Date of the transaction

13 March 2017

f)

Place of the transaction

London Stock Exchange, AIM (LON:EME)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMGMFGFRGNZM
Date   Source Headline
15th Jun 20127:00 amRNSFurther re: US$50m Debt Facility
31st May 20122:32 pmRNSResult of AGM
30th May 20124:15 pmRNSFurther re: US$50m Debt Facility
15th May 20128:15 amRNSAurora aquisition of 6% interest in Sugarloaf
8th May 20127:00 amRNSNotice of AGM and posting of results
3rd May 20127:47 amRNSOffer for Eureka Energy Limited by Aurora Oil&Gas
3rd May 20127:00 amRNSFinal Results
30th Apr 20129:14 amRNSOFFER FOR EUREKA ENERGY LIMITED BY AURORA OIL&GAS
18th Apr 20127:00 amRNSUS$50m Debt Facility
3rd Apr 20121:24 pmRNSConversion of Loan
27th Mar 201210:22 amRNSExercise of Options
23rd Mar 20127:00 amRNSEmpyeran mandates a US$50m Debt Facility
6th Mar 20122:30 pmRNSDirector/PDMR Shareholding
2nd Mar 201210:33 amRNSReplacement: US$1m sale of Hercules asset
2nd Mar 20128:27 amRNSUS$1m sale of Hercules asset and grant of options
1st Mar 20129:04 amRNSInstitutional Placing for £300,000
17th Feb 20121:29 pmRNSConversion of Loan
11th Jan 20127:24 amRNSSugarloaf Project Update
3rd Jan 20129:14 amRNSExtension of Convertible Loan Facility
22nd Dec 20117:26 amRNSTrading Statement
21st Dec 20117:06 amRNSSugarloaf Project Update
2nd Dec 20113:28 pmRNSReplacement: Half Yearly Report
2nd Dec 20117:00 amRNSHalf Yearly Report
1st Dec 20114:29 pmRNSConversion of Loan
1st Dec 20117:00 amRNSChange of Principal Office
28th Oct 201110:14 amRNSReplacement: Independent reserves report
28th Oct 20117:55 amRNSSugarloaf Project, Independent reserves report
27th Oct 20114:13 pmRNSConversion of Loan
25th Oct 20114:19 pmRNSConversion of Loan
24th Oct 20117:17 amRNSSugarloaf Project Update
19th Oct 20113:30 pmRNSConversion of Loan
15th Sep 20119:47 amRNSSugarloaf Project Update
31st Aug 201111:42 amRNSConversion of Loan - REPLACEMENT
24th Aug 20118:54 amRNSIssue of Equity
16th Aug 20119:43 amRNSDirector/PDMR Shareholding
15th Aug 20118:11 amRNSSugarloaf Update
19th Jul 20117:19 amRNSFurther re Sugarloaf Update
24th Jun 20111:30 pmRNSResult of AGM
14th Jun 20117:00 amRNSSugarloaf Project Update
3rd Jun 20117:59 amRNSTrading Statement
2nd Jun 20117:59 amRNSSugarloaf Project Update
31st May 201110:03 amRNSNotice of AGM
25th May 20117:00 amRNSFinal Results
13th May 20117:00 amRNSSugarloaf Project Update
29th Mar 201112:48 pmRNSGrant of options and Directorate change
22nd Mar 20118:22 amRNSInvestor Roadshow
10th Mar 20113:00 pmRNSDirector/PDMR Shareholding
9th Mar 20117:13 amRNSSugarloaf Project, Independent reserves report
28th Feb 20118:48 amRNSCORRECTION: Sugarloaf Update
28th Feb 20117:16 amRNSSugarloaf Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.